HIV-type O Envelope

Human Immunodeficiency Virus Type O Antigen

recombinant, E. coli

Cat. No. Amount Price (EUR) Buy / Note
PR-1209 100 μg 207,00 Add to Basket/Quote Add to Notepad

For in vitro use only!

Shipping: shipped on blue ice

Storage Conditions: store at -20 °C
avoid freeze/thaw cycles

Shelf Life: 12 months

Purity: > 95 % (SDS-PAGE, RP-HPLC)

Form: liquid (Supplied in 20 mM PBS pH 7.8, 0.5 M NaCl, 1 mM DTT, 8 M urea and 0.4 M imidazole)

pH: 7.8

Recombinant HIV type-O peptide, containing the HIV type-O transmembrane envelopederived specific sequence. Detects all clades of HIV type-O infected individuals responding to HIV type-O envelope proteins. The protein was purified by proprietary chromatographic technique.
Background: HIV belongs to the retrovirus family, distinguished by possession of a viral reverse transcriptase that transcribes viral RNA into DNA which is integrated into the host-cell genome. Based on genetic variability in the envelope (env) gene, HIV-1 can be subdivided into at least 10 distinct subtypes (designated A to J) responsible for separate geographic pandemics. Phylogenetic analyses have shown that each subtype in this major group (group M) is approximately equidistant from the others, as if arising from a common ancestor. In contrast, a few divergent HIV-1 strains form a cluster distinct from group M and have been categorized as members of the outlier group (group O).

May be used in ELISA and Western blots, excellent antigen for early detection of HIV seroconvertors with minimal specificity problems.

Specificity: Immuno reactive with all sera of HIV type-O infected individuals.

Selected References:
Payan et al. (2003) [Measuring the HIV viral load with LCx (Abbott): importance for the therapeutic follow-up of 3 patients infected by type O HIV]. Transfus. Clin. Biol. 10:72.
Miguel et al. (1998) Analysis of pol Gene Heterogeneity, Viral Quasispecies, and Drug Resistance in Individuals Infected with Group O Strains of Human Immunodeficiency Virus Type 1. J. Virol. 72:9002.